Indication
Plasmodium malariae malaria prevention
*Plasmodium malariae* malaria prevention refers to chemoprophylaxis and exposure-reduction strategies aimed at averting infection and clinical disease caused by the protozoan parasite *Plasmodium malariae*. Read more about Plasmodium malariae malaria prevention
37 drugs 36 manufacturers
Drugs that treat it
Common Plasmodium malariae malaria prevention therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Plasmodium malariae* malaria prevention refers to chemoprophylaxis and exposure-reduction strategies aimed at averting infection and clinical disease caused by the protozoan parasite *Plasmodium malariae*.
Primarily targeted toward non-immune travelers and populations living in or visiting endemic tropical and subtropical areas, this intervention protects the hematologic and reticuloendothelial systems from erythrocyte invasion.
Pathophysiologically, *P.
malariae* invades mature erythrocytes and exhibits a characteristic 72-hour schizogonic cycle, which can cause quartan fever paroxysms, chronic low-density parasitemia, and potential immune complex-mediated complications such as glomerulonephritis if left unchecked.
Prevention strategies suppress or eliminate the pre-erythrocytic hepatic stage or blood-stage schizonts before symptomatic parasitemia develops.
- nih.gov
*Plasmodium malariae* malaria prevention refers to chemoprophylaxis and exposure-reduction strategies aimed at averting infection and clinical disease caused by the protozoan parasite *Plasmodium malariae* Primarily targeted toward non-immune travelers and populations living in or visiting endemic tropical and subtropical areas, this intervention protects the hematologic and reticuloendothelial systems from erythrocyte invasion Pathophysiologically, *P. malariae* invades mature erythrocytes and ...
- nih.gov
*Plasmodium malariae* malaria prevention refers to chemoprophylaxis and exposure-reduction strategies aimed at averting infection and clinical disease caused by the protozoan parasite *Plasmodium malariae*
- cdc.gov
Primarily targeted toward non-immune travelers and populations living in or visiting endemic tropical and subtropical areas, this intervention protects the hematologic and reticuloendothelial systems from erythrocyte invasion
- nih.gov
Primarily targeted toward non-immune travelers and populations living in or visiting endemic tropical and subtropical areas, this intervention protects the hematologic and reticuloendothelial systems from erythrocyte invasion
Personalize your experience
Follow Plasmodium malariae malaria prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.